KRYS
Krystal Biotech, Inc.
$315.34+16.79 (+5.62%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Sep 20, 2017 – Nov 18, 2026, Dividends reinvested
- Final balance
- $296,372
- CAGR
- +44.77%
- Max drawdown
- −53.42%
Trailing returns (%)
KRYS's average annual return was 44.47% over the last 5 years, through Nov 18, 2026. $10,000 in KRYS on Nov 18, 2021 grew to $62,930 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −0.39%
- 3M
- −5.25%
- 6M
- +8.09%
- YTD
- +27.91%
- 1Y
- +54.02%
Per year
- 3Y
- +44.66%
- 5Y
- +44.47%
- Since 2017
- +44.77%
Annual returns
2017 from Sep 20 · 2026 through Nov 18
KRYS returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +27.91% |
| 2025 | +57.37% |
| 2024 | +26.28% |
| 2023 | +56.60% |
| 2022 | +13.25% |
| 2021 | +16.58% |
| 2020 | +8.34% |
| 2019 | +166.51% |
| 2018 | +97.53% |
| 2017 from Sep 20 | −1.13% |
Metrics
Since 2017| Volatility | 72.93% |
|---|---|
| Sharpe ratio | 0.82 |
| Sortino ratio | 1.53 |
| Calmar ratio | 0.84 |
| Longest drawdown | 1.4 years |
Worst drawdowns
Since 2017| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −53.4% | Mar 2021 | Nov 2021 | Nov 2021 | 9 months |
| −46.6% | Feb 2020 | Mar 2020 | Jan 2021 | 11 months |
| −44.5% | Nov 2021 | May 2022 | Apr 2023 | 1.4 years |
| −42.3% | Jul 2024 | May 2025 | Nov 2025 | 1.3 years |
| −35.3% | Jul 2019 | Oct 2019 | Nov 2019 | 4 months |